BREAKING
ZTO Express Fiscal Year 2025 Financial Review 3 hours ago Modiv Industrial (MDV) Declares $0.29 Monthly Dividend With 8.23% Yield, Ex-Date March 31 4 hours ago Fifth Third Bancorp (FITB) Declares $0.40 Quarterly Dividend, 3.68% Yield; Ex-Date March 31 4 hours ago Titan Machinery (TITN) Reports Wider Q4 Loss of $1.43/Share vs $0.63 Estimate Despite Revenue Beat 5 hours ago Aveanna Healthcare Reports Strong 2025 Financial Results 6 hours ago Tejon Ranch (TRC) Q4 Revenue Surges 29.9% to $23.3M, Beating Estimates by 67.6% 6 hours ago Duluth Trading Company Q4 Financial Update 6 hours ago Lands’ End (LE) Q4 EPS Beats by 27.3% at $0.76, Revenue Misses at $462.4M 7 hours ago Hello Group (MOMO) Misses Q4 EPS by 84.3% as Revenue Plunges 86.0% Year-Over-Year 7 hours ago Williams-Sonoma, Inc. Fiscal 2025 Financial Performance 8 hours ago ZTO Express Fiscal Year 2025 Financial Review 3 hours ago Modiv Industrial (MDV) Declares $0.29 Monthly Dividend With 8.23% Yield, Ex-Date March 31 4 hours ago Fifth Third Bancorp (FITB) Declares $0.40 Quarterly Dividend, 3.68% Yield; Ex-Date March 31 4 hours ago Titan Machinery (TITN) Reports Wider Q4 Loss of $1.43/Share vs $0.63 Estimate Despite Revenue Beat 5 hours ago Aveanna Healthcare Reports Strong 2025 Financial Results 6 hours ago Tejon Ranch (TRC) Q4 Revenue Surges 29.9% to $23.3M, Beating Estimates by 67.6% 6 hours ago Duluth Trading Company Q4 Financial Update 6 hours ago Lands’ End (LE) Q4 EPS Beats by 27.3% at $0.76, Revenue Misses at $462.4M 7 hours ago Hello Group (MOMO) Misses Q4 EPS by 84.3% as Revenue Plunges 86.0% Year-Over-Year 7 hours ago Williams-Sonoma, Inc. Fiscal 2025 Financial Performance 8 hours ago
ADVERTISEMENT
JNJ

Johnson & Johnson

$JNJ NYSE Feb 24, 2026 All Day FY 2026

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Visual summary of key financial data.

View Infographic

Earnings History

View past quarters and earnings trends.

View History

JNJ Coverage

Event Johnson & Johnson (JNJ) FDA approval of ICOTYDE™ (icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide Mar 18, 2026 Event Johnson & Johnson (JNJ) Johnson & Johnson highlights promising first-in-human Erda-iDRS (formerly TAR-210) results in intermediate-risk non-muscle-invasive bladder cancer Mar 13, 2026 Event Johnson & Johnson (JNJ) Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients Mar 12, 2026 Transcript Johnson & Johnson (JNJ) Q4 2025 Earnings Call Transcript Jan 26, 2026 Transcript Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Infographic: How Johnson & Johnson (JNJ) performed in Q4 2025 Jan 21, 2026 Research Johnson & Johnson: Healthcare Outlook Jan 20, 2026